在SARS-CoV-2肺炎和艾森门格综合征:加倍的挑战
Paola Pierucci1, Lucrezia De Michele2, Maria Luisa De Candia1
1Respiratory and Critical Care Unit, Cardiothoracic Department, Bari Policlinic University Hospital; Section of Respiratory Diseases, Department of Basic Medical Science Neuroscience and Sense Organs, University of Bari "Aldo Moro".
概括
高流量鼻腔管 (HFNC) 氧气疗法是艾森曼格尔急性缺血性呼吸衰竭的安全第一线治疗方法.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 关键护理医学 关键护理医学
背景情况:
- 艾森门格综合征 (ES) 是与先天性心脏病相关的最严重的肺动脉高血压形式.
- 在ES中,左向右的转移会导致肺血管疾病和高血压.
- 在ES中,急性缺血性呼吸衰竭带来了重大管理挑战.
研究的目的:
- 评估高流量鼻 (HFNC) 氧气治疗在患有艾森门格综合征和COVID-19的患者中的有效性和安全性.
- 突出HFNC作为潜在的第一线治疗,以减轻与ES的正压通风相关的风险.
主要方法:
- 病例报告详细介绍了ES和COVID-19患者的临床过程.
- 在急性缺血性呼吸衰竭中使用HFNC.
主要成果:
- 使用HFNC.成功管理低血压呼吸衰竭.
- 避免正压通风和相关的并发症.
结论:
- 在患有艾森门格综合征的患者中,HFNC可以成为急性低血量呼吸衰竭的有价值和安全的第一线治疗方法.
- 这种方法可能有助于预防肺部并发症和右心室过载.
相关概念视频
01:29Pulmonary Embolism I: Introduction
7
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
7
01:30Pneumonia III: Complications and Assessment
241
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
241
01:29Pneumonia II: Pathophysiology
293
The pathophysiology of pneumonia involves the following steps:
293
01:26Acute Coronary Syndrome V: Nursing Management
15
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
15
01:21Acute Respiratory Failure-II
249
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
249
01:30Acute Respiratory Failure-III
190
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
190